Clinical trial
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction…
NCT00091637 · Procter and Gamble, Industry · Completed
Key facts
| NCT number | NCT00091637 |
|---|---|
| Title | Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) |
| Official title | APEX-AMI - Pexelizumab in Conjunction With Angioplasty |
| Lead sponsor | Procter and Gamble, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Pexelizumab, Placebo infusion |
| Enrollment | 5,745 |
| Start date | Apr 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 16, 2004 |
| Last update posted | Nov 18, 2023 |
| Countries | Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Italy, Netherlands, New Zealand, Poland and 5 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: